Peer-influenced content. Sources you trust. No registration required. This is HCN.
MedTech Dive
GE HealthCare’s Portrait Mobile, recently cleared by the FDA, offers a novel approach to patient monitoring, allowing continuous oversight without confining patients to their beds. Explore how this innovative technology could redefine hospital care practices.
Cardiology August 23rd 2023
British Medical Journal
The recent FDA approval of brexpiprazole for Alzheimer’s dementia patients has ignited concerns among healthcare professionals. Physicians are urged to carefully consider the drug’s minimal efficacy and increased mortality risk in their treatment decisions.
Geriatrics August 22nd 2023
Practical Neurology
The FDA’s approval of Daxxify offers a promising new treatment for cervical dystonia. Explore the comprehensive clinical data that supports this peptide-formulated neuromodulator’s efficacy and safety profile.
Neurology August 22nd 2023
Medical Professionals Reference (MPR)
The FDA’s recent approval of Akeega, a combination therapy for BRCA-mutated mCRPC, marks a significant advancement in targeted treatment. This approval, based on the MAGNITUDE study, offers a new therapeutic option for patients, supported by robust clinical data.
Oncology, Medical August 21st 2023
OBR Oncology
The FDA’s accelerated approval of elranatamab offers a new therapeutic pathway for adults with relapsed or refractory multiple myeloma. With promising response rates and an established safety profile, this treatment may provide a much-needed option for those struggling with relapsed myeloma.
Hematology/Oncology August 21st 2023
The updated prescribing guidelines for Wegovy (semaglutide) offer new maintenance dosing options for adults, reflecting recent research findings.
Endocrinology, Diabetes, Metabolism August 16th 2023